Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02633891 · ClinicalTrials.gov registry record · NA
Metabolic Syndrome and Fall Risk
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02633891: Completed NA study, sponsored by VA Office of Research and Development.
NCT02633891 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02633891, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Obesity and the metabolic syndrome (MetS) are rapidly growing problems. Individuals with the MetS are at risk for not only future chronic diseases, but they have a higher prevalence of neuropathy, including cardiac autonomic neuropathy, and have a higher incidence of falls. Currently there are no effective therapies to prevent or reverse the neuropathy seen in the MetS or to reduced the fall risk in this population. This research project will determine if a tailored balance exercise program will have functional benefits and result in a reduced fall risk in the growing population of patients with the MetS and neuropathy.
Interventions
- BEHAVIORAL Standard care
- BEHAVIORAL Balance exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-01-02 |
| Est. Completion | 2022-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02633891
The ClinicalTrials.gov registry entry for NCT02633891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard care is the first listed.
NCT02633891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02633891 about?
NCT02633891 is a clinical study titled "Metabolic Syndrome and Fall Risk". Obesity and the metabolic syndrome (MetS) are rapidly growing problems. Individuals with the MetS are at risk for not only future chronic diseases, but they have a higher prevalence of neuropathy, including cardiac autonomic neuropathy, and have a higher incidence of falls. Currently there are no ef...
What is the current status of trial NCT02633891?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-01-02. Estimated completion is 2022-03-28.
What interventions are being tested in trial NCT02633891?
The interventions under investigation include: Standard care (BEHAVIORAL), Balance exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02633891?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.